Recent Advances in Engineered Materials for Immunotherapy-Involved Combination Cancer Therapy
- PMID: 34050564
- DOI: 10.1002/adma.202007630
Recent Advances in Engineered Materials for Immunotherapy-Involved Combination Cancer Therapy
Abstract
Immunotherapy that can activate immunity or enhance the immunogenicity of tumors has emerged as one of the most effective methods for cancer therapy. Nevertheless, single-mode immunotherapy is still confronted with several critical challenges, such as the low immune response, the low tumor infiltration, and the complex immunosuppression tumor microenvironment. Recently, the combination of immunotherapy with other therapeutic modalities has emerged as a powerful strategy to augment the therapeutic outcome in fighting against cancer. In this review, recent research advances of the combination of immunotherapy with chemotherapy, phototherapy, radiotherapy, sonodynamic therapy, metabolic therapy, and microwave thermotherapy are summarized. Critical challenges and future research direction of immunotherapy-based cancer therapeutic strategy are also discussed.
Keywords: cancer; combination therapy; engineered materials; immunotherapy; synergistic effect.
© 2021 Wiley-VCH GmbH.
References
-
- a) D. J. Irvine, E. L. Dane, Nat. Rev. Immunol. 2020, 20, 321;
-
- b) S. Yang, T. Lammers, Acc. Chem. Res. 2019, 52, 1543;
-
- c) S. L. Topalian, J. M. Taube, D. M. Pardoll, Science 2020, 367, 6477;
-
- d) M. Chen, G. Quan, T. Wen, P. Yang, W. Qin, H. Mai, Y. Sun, C. Lu, X. Pan, C. Wu, ACS Appl. Mater. Interfaces 2020, 12, 32259.
-
- a) R. S. Riley, C. H. June, R. Langer, M. J. Mitchell, Nat. Rev. Drug Discovery 2019, 18, 175;
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical